Transplanted human retinal stem cells can successfully regenerate

University of Toronto researchers have shown that human retinal stem cells transplanted into the eyes of mice and chicks can successfully regenerate.

The research, published in the Oct. 19 issue of The Proceedings of the National Academy of Sciences, documents the development of transplanted human retinal stem cells into light-sensing photoreceptor cells and retinal pigment epithelial (RPE) cells, the cells which bounce light and images back onto the retina.

"We transplanted the cells early in the animals' development when all the nutrients and signals they needed for differentiation were still there," says lead author Brenda Coles, a U of T laboratory technician working under the supervision of Professor Derek van der Kooy in the Department of Medical Genetics and Microbiology. "When their eyes fully developed, the human cells survived, migrated into the sensory part of the eye and formed the correct cells."

The research has implications for future treatment of degenerative eye diseases such as retinitis pigmentosa and macular degeneration but that's still a long way off, says Coles. She, van der Kooy and their colleagues are now exploring whether retinal stem cells from healthy mice continue to develop into photoreceptor cells and RPE cells when transplanted to mice with diseased eyes.

"We're starting with mice to see if they can overcome the genetics involved in disease," says Coles. "The eye itself is telling the stem cells what to do, so when we go to a disease model, it is important to know what those signals from the eye are so we can inhibit them or protect the cells."

The other researchers involved in this study are U of T's Prof. Roderick McInnes, and post-doctoral fellow Tomoyuki Inoue, Department of Medical Genetics and Microbiology; Brigitte Angenieux and Yvan Arsenijevic, Hopital Ophtalmique Jules Gonin, Lausanne, Switzerland; and Katia Del Rio-Tsonis, Miami University, Ohio.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool maps millions of CD8+ T cells to advance disease research